Unique ID issued by UMIN | UMIN000021010 |
---|---|
Receipt number | R000024216 |
Scientific Title | Clinical study comparing the effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer with PPI : a case controlled study. |
Date of disclosure of the study information | 2016/02/14 |
Last modified on | 2016/07/23 19:16:16 |
Clinical study comparing the effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer with PPI : a case controlled study.
Effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer
Clinical study comparing the effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer with PPI : a case controlled study.
Effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer
Japan |
Post-ESD(endoscopic submucosal dissection) artificial gastric ulcer
Gastroenterology |
Malignancy
NO
The aim of this study was to assess the effect of treatment for post-ESD ulcers by Vonoprazan at 5weeks at cost equivalent to proton pomp inhibitor(PPI) at 8weeks.
Safety,Efficacy
Confirmatory
Not applicable
We assessed the rate of decrease in ulcer size and the postoperative bleeding rate
Observational
20 | years-old | <= |
Not applicable |
Male and Female
The study subjects were 75 consecutive patients who treated by Vonoplazan (20mg /day, 5week) after endoscopic submucosal dissection(ESD) for early gastric neoplasm from April 2014 to February 2015 at our hospital.
Control subjects were selected from among 870 patients who had treated by PPI(Rabeprazole 20mg/day, 8week) for artificial gastric ulcer after endoscopic submucosal dissection(ESD) from April 2005 to March 2014 at our hospital.
Age-, sex-, the size of ulcer- and Helicobacter pylori infection-matched two control subjects were selected for one case subject(control group).
Patients who received additional chemotherapy or surgical treatment after endoscopic submucosal dissection(ESD)
Patients who discontinued Vonoprazan due to side effects
Remnant stomach
75
1st name | |
Middle name | |
Last name | Shigenao Ishikawa |
Kagawa Prefectural Central Hospital
Department of Gastroenterology
1-2-1 Asahi-machi,Takamatsu, Kagawa, Japan
087-811-3333
ishikawa5308@yahoo.co.jp
1st name | |
Middle name | |
Last name | Shigenao Ishikawa |
Kagawa Prefectural Central Hospital
Department of Gastroenterology
1-2-1 Asahi-machi,Takamatsu, Kagawa, Japan
087-811-3333
ishikawa5308@yahoo.co.jp
Kagawa Prefectural Central Hospital
none
Other
NO
2016 | Year | 02 | Month | 14 | Day |
Published
Completed
2014 | Year | 02 | Month | 01 | Day |
2014 | Year | 04 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2016 | Year | 02 | Month | 01 | Day |
2016 | Year | 02 | Month | 01 | Day |
2016 | Year | 02 | Month | 28 | Day |
The aim of this study was to assess the effect of the Vonoprazan and the PPI for the ulcer healing and the prevention of bleeding after ESD.
The study subjects were consecutive patients who underwent ESD for superficial gastric neoplasm. Comparison objects were 150 patients who were treated by PPI for post-ESD ulcers.We assessed the rate of decrease in ulcer size and the postoperative bleeding rate in the two groups.
This study was case-control study.
2016 | Year | 02 | Month | 13 | Day |
2016 | Year | 07 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024216
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |